Results 81 to 90 of about 214,511 (232)

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans [PDF]

, 2013
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP).
Both, L, Bulmer-Thomas, B., Banyard, AC, Selden, D., Altmann, F, Craig van Dolleweerd (406086), David Selden (4911475), Selden, D, Ashley C Banyard (16267520), Both, L., Banyard, A.C., Edward Wright (4468198), Bulmer-Thomas, B, Fooks, AR, Friedrich Altmann (33138), Wright, E, van Dolleweerd, C., Fooks, A.R., Ma, J.K.C., Julian K C Ma (16267529), Leonard Both (16267517), van Dolleweerd, C, Ma, JK, Wright, E., Altmann, F., Anthony R Fooks (16267526), Bianca Bulmer-Thomas (16267523)   +26 more
core   +1 more source

Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia

Haematologica, 2010
Background Invasive aspergillosis is a common life-threatening infection in patients with acute leukemia. The presence of building work near to hospital wards in which these patients are cared for is an important risk factor for the development of ...
Amélie Chabrol, Lise Cuzin, Françoise Huguet, Muriel Alvarez, Xavier Verdeil, Marie Denise Linas, Sophie Cassaing, Jacques Giron, Laurent Tetu, Michel Attal, Christian Récher   +10 more
doaj   +1 more source

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. [PDF]

, 2013
Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice.
A. Loyse, Dromer, F, Day, J, Lortholary, O, O. Lortholary, Harrison, TS, F. Dromer, Day, Jeremy, T. S. Harrison, J. Day, Loyse, A   +10 more
core   +1 more source

Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?

International Journal of Infectious Diseases, 2019
Objectives: Recommendations in clinical practice guidelines (CPG) may differ and cause confusion. Our objective was to appraise CPGs for antifungal treatment of invasive candidiasis (IC) in non-neutropenic critically ill adult patients.
Yan Wang, Treasure M. McGuire, Samantha A. Hollingworth, Yalin Dong, Mieke L. Van Driel   +4 more
doaj   +1 more source

Fecal Microbiota Transplantation and Microbiota‐Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions

Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 871-889, October 2026.
The intestinal microbiome is a key regulator of immune homeostasis, metabolism, and epithelial barrier integrity. In patients with malignant hematological diseases, particularly those undergoing hematopoietic stem cell transplantation, microbiome perturbations by reduced diversity, pathobiont expansion, and loss of beneficial metabolites are common as ...
Bálint Gergely Szabó, Dorina Korózs, Michal Bator, Krisztina Jeszenszky, Viktor Lakatos, László Gopcsa, Péter Reményi, János Sinkó   +7 more
wiley   +1 more source

Willingness-to-pay for antibacterial and antifungal prophylaxis^*.

, 2012
*Willingness-to-pay for each scenario (95% confidence interval). Antibacterial prophylaxis scenario consists of the following for chances of infection, death and side effects for prophylaxis versus no prophylaxis: 25%, 1% and 25% versus 50%, 2%, 15 ...
Marie-Chantal Ethier (127692), Jonathan Taylor (127703), Amanda Alli (127695), Lillian Sung (127709), Caroline Diorio (127690), Denise Mills (127706), Dean A. Regier (127689), Katherine M. Boydell (127701), Adam Gassas (127702), Sarah Alexander (127698), Charis Kellow (127704)   +10 more
core   +1 more source

Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients [PDF]

, 2011
Data on antifungal prophylaxis in paediatric cancer patients at high risk for invasive fungal disease (IFD) are scant. Intermittent administration of liposomal amphotericin B (LAMB) has been shown to be safe and effective in adult patients with ...
K. Bochennek, Lehrnbecher, T., T. Lehrnbecher, Bochennek, K., M. Becker, L. Tramsen, A.H. Groll, N. Schedler, Groll, A.H., Klingebiel, T., T. Klingebiel, Schedler, N., Tramsen, L., Becker, M.   +13 more
core   +1 more source

Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treatment

Turkish Journal of Hematology
Invasive fungal diseases (IFDs) remain a significant cause of morbidity and mortality among patients with hematological malignancies, especially those undergoing intensive chemotherapy or hematopoietic stem cell transplantation (HSCT). This text provides
Vildan Özkocaman, Tuğcan Alp Kırkızlar, Gökhan Metan, Ömrüm Uzun, İbrahim Ethem Pınar, Fahir Özkalemkaş, Muhlis Cem Ar, Murat Akova   +7 more
doaj   +1 more source

Prevalence of Antimicrobial Use in Small Animal Dermatology Referral Practices in the United States

Veterinary Dermatology, Volume 37, Issue 5, Page 581-591, October 2026.
ABSTRACT Background Antimicrobial resistance is a critical global health concern driven by antimicrobial use. Dermatological conditions are common reasons for antimicrobial prescriptions in small animal practice, yet data on prescribing patterns in veterinary dermatology referral settings are lacking. Hypothesis/Objectives To characterise the frequency,
Domenico Santoro, Emma R. Bollig, Jennifer L. Granick   +2 more
wiley   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, Volume 600, Issue 17, Page 2526-2546, September 2026.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source